Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- MHRA guidance on Coronavirus (COVID-19)
- Drug and device alerts
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Blood regulation and safety
- Marketing authorisations and licensing guidance
- Patient information leaflets and summaries of product characteristics
- Public assessment reports
- Medical devices regulation and safety
- Contact MHRA
- All MHRA services and information
Featured
Collection
MHRA guidance on coronavirus (COVID-19)
We are producing guidance for industry covering the coronavirus (COVID-19) outbreak.
Guidance
Specification for Rapidly Manufactured CPAP System to be used during the coronavirus (COVID-19) outbreak
This is a specification of the minimally clinically acceptable Continuous Positive Airway Pressure (CPAP) system to be used in UK hospitals.
Government response
Coronavirus (COVID-19) and high blood pressure medication
There is no evidence from clinical or epidemiological studies that treatment with ACE-I or ARBs might worsen COVID-19 infection.
Detailed guide
Regulatory status of equipment being used to help prevent coronavirus (COVID-19)
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
Detailed guide
Exemptions from Devices regulations during the coronavirus (COVID-19) outbreak
Fast-track approval of medical devices during COVID-19 outbreak
Detailed guide
Clinical trials applications for Coronavirus (COVID-19)
The MHRA is ready to prioritise and provide any assistance for clinical trials applications submitted for COVID-19
Latest from the Medicines and Healthcare products Regulatory Agency
What the Medicines and Healthcare products Regulatory Agency does
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Policy papers and consultations
- MHRA consultation on EU exit no-deal legislative proposals
- How should we engage and involve patients and the public in our work
Transparency and freedom of information releases
- Clinical trials for medicines: authorisation assessment performance
- MHRA: policy for handling conflicts of interest
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Please get in touch with us by phone or email during the coronavirus (COVID-19) response period.
In line with the Government’s advice, our building at 10 South Colonnade will close at 5pm on Friday 27 March. It will remain closed until at least week commencing Monday 13 April, at which point the decision will be reviewed.
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhrapress
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
Corporate information
Jobs and contracts